Atherosclerosis

Carotid Plaque, Vascular Disease Event Risk Increase With HIV

Carotid Plaque, Vascular Disease Event Risk Increase With HIV

By

Findings show that HIV status was associated with an increased rate of incidental carotid plaque, noncalcified plaque, and high-risk plaque.

Simpler Tool Effectively Evaluates Subclinical Atherosclerosis Risk

Simpler Tool Effectively Evaluates Subclinical Atherosclerosis Risk

The ideal cardiovascular health score and the Fuster-BEWAT score are similar in their ability to predict subclinical atherosclerosis.

Atherosclerotic CVD Benefits From Statins

Atherosclerotic CVD Benefits From Statins

For patients who have experienced an atherosclerotic cardiovascular disease event, receipt of statins, especially high-intensity statins, is associated with reduced risk of major adverse cardiac events.

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

By

Anti-inflammatory therapy with canakinumab may result in a significantly lower incidence of lung cancer and lung cancer mortality.

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Black men have increased prevalence and frequency of multiple intracranial atherosclerotic plaques.

Effect of Exercise on Coronary Artery Calcification

Effect of Exercise on Coronary Artery Calcification

White males who participate in 3 times the recommended physical activity over many years have higher odds of developing coronary subclinical atherosclerosis.

Reduced Forced Vital Capacity May Be Useful for Risk Assessment of Arterial Stiffness

Reduced Forced Vital Capacity May Be Useful for Risk Assessment of Arterial Stiffness

By

Restrictive spirometry pattern and reduced forced vital capacity level are associated with increased risk of arterial stiffness.

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden death is the most common category of cardiovascular mortality among patients with type 2 diabetes and atherosclerotic CVD.

Coronary Artery Calcium Useful in Predicting Cardiovascular Risk in COPD

Coronary Artery Calcium Useful in Predicting Cardiovascular Risk in COPD

By

Coronary artery calcium may be the best noninvasive risk marker for predicting a major cardiovascular event in patients with COPD.

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

By

Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.

Atherosclerosis Risk Increased When Skipping Breakfast

Atherosclerosis Risk Increased When Skipping Breakfast

Habitual skipping of breakfast is associated with increased likelihood of atherosclerosis independent of traditional and dietary cardiovascular risk factors.

Anacetrapib Reduces Major Coronary Events When Added to Intensive Statin Therapy

Anacetrapib Reduces Major Coronary Events When Added to Intensive Statin Therapy

Lower incidence of major coronary events for patients with atherosclerotic vascular disease receiving intensive statins is linked with use of anacetrapib.

PCSK9 Inhibitor Evolocumab Continues to Lack Cost-Effectiveness

PCSK9 Inhibitor Evolocumab Continues to Lack Cost-Effectiveness

Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

By

Despite more major bleeding events, rivaroxaban plus aspirin therapy had a greater cardiovascular benefit in patients with stable atherosclerotic vascular disease vs monotherapy.

Role of Race and Ethnicity in Cardiovascular Health

Role of Race and Ethnicity in Cardiovascular Health

By

Experts weigh in on how to improve racial and ethnic disparities in cardiovascular health.

Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVD

Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVD

By

Fourteen percent of study participants experienced incident athersclerotic cardiovascular disease events.

Gray Hair Predictive of Coronary Artery Disease in Men

Gray Hair Predictive of Coronary Artery Disease in Men

By

Hair whitening score, hypertension, and dyslipidemia were all independent predictors of atherosclerotic coronary artery disease.

FOURIER Trial Data Questions: Are PCSK9 Inhibitors The Right Choice?

FOURIER Trial Data Questions: Are PCSK9 Inhibitors The Right Choice?

Results of the FOURIER trial, presented at the 2017 ACC Scientific Sessions, raise questions about the efficacy of PCSK9 inhibitors as long-term therapy for patients with atherosclerotic CVD.

Patient-Clinician Communication Key in Managing Heart Disease Treatment

Patient-Clinician Communication Key in Managing Heart Disease Treatment

Two studies examined the positive outcomes of clear patient-clinician communication on management and treatment of heart disease.

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

A mutlimodal strategy combines 5 separate tests to significantly improve CVD and ASVCD risk assessment.

Statin Eligibility Requirements In African Americans With Atherosclerosis

Statin Eligibility Requirements In African Americans With Atherosclerosis

According to ACC/AHA Guidelines presented at ACC 2017, targeted imaging should be used to personalize statin recommendation programs.

LDL-C Lowered Below Current Targets Beneficial to Atherosclerotic CVD

LDL-C Lowered Below Current Targets Beneficial to Atherosclerotic CVD

By

Evolocumab reduced LDL-C levels by 59% and lowered the risk of CV death, MI, stroke, hospitalization for unstable angina, or coronary revascularization by 15%.

Hormone Replacement Therapy Associated With Lower Coronary Artery Calcium Scores

Hormone Replacement Therapy Associated With Lower Coronary Artery Calcium Scores

By

Hormone replacement therapy in postmenopausal women was associated with lower coronary artery calcium scores as well as lower risk of long-term all-cause mortality.

Oxidized Lipoprotein Biomarker Levels Affected by Age, Ethnicity

Oxidized Lipoprotein Biomarker Levels Affected by Age, Ethnicity

By

Elevated IgG MDA-LDL levels are associated with a higher risk of subclinical atherosclerosis and may serve as accurate predictors of MACE

Increased Cardiovascular Disease Risk With Darunavir Therapy

Increased Cardiovascular Disease Risk With Darunavir Therapy

By

Risk of cardiovascular disease gradually increased in patients undergoing darunavir therapy.

Care Setting Impacts Carotid Artery Stenosis Management

Care Setting Impacts Carotid Artery Stenosis Management

Patients were more likely to undergo procedural management in a fee-for-service system vs a salary-based system.

Amygdalar Activity Independently Predicts Cardiovascular Events

Amygdalar Activity Independently Predicts Cardiovascular Events

By

Chronic stress identified as risk factor for cardiovascular disease.

CVD, Atherosclerosis Risk in Systemic Lupus Erythematosus

CVD, Atherosclerosis Risk in Systemic Lupus Erythematosus

By

Patients with systemic lupus erythematosus had a net progression of mean carotid intima-media thickness, with or without depression.

Coronary Heart Disease in HIV/AIDS: Confronting 2 Major Health Issues

Coronary Heart Disease in HIV/AIDS: Confronting 2 Major Health Issues

By

A review of cardiovascular disease burden, particularly coronary heart disease, in HIV/AIDS.

Coronary Atherosclerosis Prevalence in Psoriatic Arthritis

Coronary Atherosclerosis Prevalence in Psoriatic Arthritis

By

A large number of patients with psoriatic arthritis may have silent coronary artery disease.

Sign Up for Free e-Newsletters